US regulator approves pig organ transplant trial to treat kidney disease
United Therapeutics Corporation, a public benefit corporation, got approval from US regulators to start a clinical trial for organ transplantation from genetically modified.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
United Therapeutics Corporation, a public benefit corporation, got approval from US regulators to start a clinical trial for organ transplantation from genetically modified.
Urgent steps are needed to study the dynamics of the circulating viral strains about its vector, hosts and environment for developing effective preventive.
By K. Leelamoni March 2, 2024: A few days ago, I read in the newspaper about the family of a 62-year-old lady, who.
Bharti Jayshankar January 25, 2024: Scientists at the University of Alabama-Birmingham’s Marnix E. Heersink School of Medicine have successfully transplanted genetically modified pig.
HQ Team September 19, 2023: The USFDA stated that Accord Healthcare Inc.’s generic tacrolimus oral capsules, meant to treat organ rejection, were no.
HQ Team September 11, 2023: An electronic device to endlessly monitor a transplanted organ’s temperature, to detect signs of the body’s rejection, has.